Albemarle Strategic Growth Presentation
Adjusted EBITDA Supplemental¹
($ in thousands)
Adjusted EBITDA
Net income attributable to noncontrolling interests
Twelve Months
Ended
Sep 30, 2023
Three Months Ended
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
$
4,325,024
112,020
Equity in net income of unconsolidated investments (net of tax)
Dividends received from unconsolidated investments
(1,740,344)
453,287
18,160
(470,306)
2,389,569
859,786
Consolidated EBITDA
Total Long Term Debt (as reported)
Off balance sheet obligations and other
Consolidated Funded Debt
Less Cash
Consolidated Funded Net Debt
Consolidated Funded Debt to Consolidated EBITDA Ratio
$
5,086,269 $
860,927
$
1,032,266
26,396
(551,051)
531,887
1,039,498
1,595,719
$
38,123
(396,188)
547,552
1,785,206 $
Dec 31, 2022
1,243,752
29,341
(322,799)
450,344
1,400,638
3,658,322
191,200
3,849,522
1,601,668
$
2,247,854
Consolidated Funded Net Debt to Consolidated EBITDA Ratio
0.8
0.4
1 This supplemental is for net-debt-to-adjusted EBITDA ratio based on the bank covenant definition.
Albemarle 39View entire presentation